TREATMENT READING
Hodgkin Lymphoma
Choose a source section by treatment, subtype or setting. Patient and professional reading are labelled separately.
Selected text from the National Cancer Institute, with original links and dates. This Triangle reading page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
15 studies cited in this topic · see design and results →
Explore 13 related disease and treatment settings → · Source-derived catalogue; clinical review pending.
Certain factors affect prognosis (chance of recovery) and treatment options.
Hodgkin lymphoma may be grouped for treatment as follows:
Early Favorable
Early Unfavorable
Advanced
Hodgkin lymphoma can recur (come back) after it has been treated.
Treatment Option Overview
Key Points
There are different types of treatment for patients with Hodgkin lymphoma.
Patients with Hodgkin lymphoma should have their treatment planned by a team of health care providers with expertise in treating lymphomas.
Treatment for Hodgkin lymphoma may cause side effects.
The following types of treatment are used:
Chemotherapy
Radiation therapy
Targeted therapy
Immunotherapy
Chemotherapy with stem cell transplant
For patients with nodular lymphocyte–predominant Hodgkin lymphoma (NLPHL), treatment options also include:
Watchful waiting
Active surveillance
For pregnant patients with Hodgkin lymphoma, treatment options also include:
Watchful waiting
Steroid therapy
New types of treatment are being tested in clinical trials.
Patients may want to think about taking part in a clinical trial.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Follow-up care may be needed.
Treatment of Early Favorable Classic Hodgkin Lymphoma
Treatment of Early Unfavorable Classic Hodgkin Lymphoma
Treatment of Advanced Classic Hodgkin Lymphoma
Treatment of Recurrent Classic Hodgkin Lymphoma
Treatment of Nodular Lymphocyte–Predominant Hodgkin Lymphoma (NLPHL)
Treatment of Hodgkin Lymphoma During Pregnancy
Hodgkin Lymphoma During the First Trimester of Pregnancy
Hodgkin Lymphoma During the Second or Third Trimester of Pregnancy
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle